Volume 21 - Issue 8 - August 2021

Sumit Verma, MD, FHRS; Evaldas Giedrimas, MD, FHRS; Natalia Hernandez, MD; Thabet Alsheikh, MD, FHRS

Baptist Heart and Vascular Institute, Heart Rhythm Center, Pensacola, Florida

Yogamaya Mantha, MD^1,2; Uday Tatiraju, MS³; Pavan Vempaty, MS, PhD⁴; Kamala P. Tamirisa, MD, FACC, FHRS⁵

¹Texas Health Presbyterian Hospital of Dallas, Dallas, Texas; ²University of Texas Southwestern Medical Center, Institute for Exercise and Environmental Medicine, Dallas, Texas; ³Product Development, Oracle Corporation, Austin, Texas; ⁴Research and Development, Dataspeed Inc., Rochester Hills, Michigan, ⁵Texas Cardiac Arrhythmia Institute, Dallas/Austin, Texas

Marcin Kowalski, MD¹;  Wilber W. Su, MD²;  Reece Holbrook³;  Alicia Sale³; Kendra M. Braegelmann, PhD³;  Hugh Calkins, MD⁴; on behalf of the STOP Persistent AF Investigators

¹Northwell Health Staten Island University Hospital, Staten Island, New York; ²Banner University Medical Center, Phoenix, Arizona; ³Medtronic, Inc., Minneapolis, Minnesota; and ⁴Johns Hopkins Medical Institutions, Baltimore, Maryland

Daniel Garner, MbCHb¹; Goutham Meda²; Keyomi Gunarathne Mudiyansege, MbCHb¹; Victoria Pettemerides, MBBS, BSC, MRCP¹; Mark Pullan, FRCS¹; Archana Rao, MD¹

Sri Sundaram, MD, FHRS¹; Jena Humer, RN²; Dan Alyesh, MD¹; William Choe, MD¹

¹South Denver Cardiology Associates, Littleton, Colorado; ²Manager, Cardiac Cath/Electrophysiology Lab, Porter Adventist Hospital, Denver, Colorado

Maison Habkouk, RT(R); Roxanne Gardner, RCES, CRT; Yehoshua Levine, MD

Methodist University Hospital, Memphis, Tennessee